ILLUMINA MISEQDX CYSTIC FIBROSIS CLINICAL SEQUENCING ASSAY— 510(k) K132750
Substantially EquivalentIllumina, Inc.
FDA 510(k) clearance K132750 for ILLUMINA MISEQDX CYSTIC FIBROSIS CLINICAL SEQUENCING ASSAY, Substantially Equivalent on 2013-11-19. Applicant: Illumina, Inc..
Clearance details
- Applicant
- Illumina, Inc.
- Product code
- Code PFS
- Advisory panel
- Immunology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- San Diego, CA, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.